Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | GGT1 | P19440 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.37 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | GNPAT | O15228 | 1/20 | 0.33 |
| ▸ | CTH | P32929 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL232126 | 1.00 | FOLH1 (0.42) | FOLH1GGT1CPB2GSRSLC6A5 | |
| SCHEMBL27799398 | 1.00 | FOLH1 (0.42) | FOLH1GGT1CPB2GSRSLC6A5 | |
| Hydrochloric Acid SCHEMBL15923983 | 0.98 | FOLH1 (0.41) | FOLH1GGT1CPB2GSRSLC6A5 | |
| SCHEMBL45766 | 0.95 | FOLH1 (0.49) | FOLH1GGT1CPB2GSRSLC6A5 | |
| SCHEMBL6676701 | 0.95 | FOLH1 (0.49) | FOLH1GGT1CPB2GSRSLC6A5 | |
| Hydrochloric Acid SCHEMBL15923088 | 0.93 | FOLH1 (0.47) | FOLH1GGT1CPB2GSRSLC6A5 | |
| Acetic Acid SCHEMBL268741 | 0.90 | FOLH1 (0.45) | FOLH1GGT1CPB2GSRSLC6A5 | |
| SCHEMBL8843334 | 0.85 | MMP2 (0.41) | GGT1CPB2MMP2MMP9CA1 | |
| SCHEMBL1062835 | 0.82 | FOLH1 (0.42) | FOLH1GGT1CPB2GSRSLC6A5 | |
| SCHEMBL20586820 | 0.82 | FOLH1 (0.42) | FOLH1GGT1CPB2GSRSLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309521-A1 | NOVEL METHOD FOR PREPARING ANIMAL MODEL OF CEREBROVASCULAR DISEASE AND METHOD FOR PRODUCING ANIMAL HAVING SMALL INDIVIDUAL DIFFERENCE IN SUSCEPTIBILITY TO CEREBROVASCULAR DISEASE ONSET BY USING ANIMAL MODEL FOR CEREBROVASCULAR DISEASE PREPARED THEREBY | DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2023-10-05 | — | — | US | claimed |
| EP-4197323-A1 | NOVEL METHOD FOR PREPARING ANIMAL MODEL OF CEREBROVASCULAR DISEASE AND METHOD FOR PRODUCING ANIMAL HAVING SMALL INDIVIDUAL DIFFERENCE IN SUSCEPTIBILITY TO CEREBROVASCULAR DISEASE ONSET BY USING ANIMAL MODEL FOR CEREBROVASCULAR DISEASE PREPARED THEREBY | Dongguk University Industry-Academic Cooperation Foundation (KR) | 2023-06-21 | — | — | EP | claimed |
| JP-4579349-B2 | — | — | 2010-11-10 | — | — | JP | claimed |
| WO-2005105065-A2 | THIAZOLE-BASED NITRIC OXIDE DONORS FOR TREATING INFLAMMATORY BOWEL DISEASES | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | claimed |
| WO-2005046660-A1 | MODULATING SUBSTANCES OF THE NITRIC OXID (NO) - CYCLIC GUANOSINE - 3’,5’- MONOPHOSPHATE (cGMP) SIGNALING PATHWAY FOR THE TREATMENT OF DENTAL DISORDERS | CELL CENTER COLOGNE GMBH (DE) | 2005-05-26 | — | — | WO | claimed |
| WO-2003084528-A1 | A METHOD FOR REVERSING PERMEABILITY MODIFICATIONS CAUSED BY ACUTE PERITONITIS | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2003-10-16 | — | — | WO | claimed |
| EP-0797442-B1 | TREATMENT OF OPTIC NEURITIS | MASSACHUSETTS EYE & EAR INFIRM (US) | 2003-05-21 | — | — | EP | claimed |
| US-6333350-B1 | INDUCING CERVICAL DILATION USING NITRIC OXIDE DONORS | SCHERING AG (DE) | 2001-12-25 | — | — | US | claimed |
| EP-0814785-A1 | USE OF NITRIC OXIDE DONORS OR NITRIC OXIDE INHIBITORS FOR REGULATING CERVICAL DILATATION AND EXTENSIBILITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-01-07 | — | — | EP | claimed |
| WO-1996028145-A1 | USE OF NITRIC OXIDE DONORS OR NITRIC OXIDE INHIBITORS FOR REGULATING CERVICAL DILATATION AND EXTENSIBILITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-09-19 | — | — | WO | claimed |
| US-5554638-A | ADMINISTERING NITRIC OXIDE SYNTHASE INHIBITOR AND HYPOXIC CYTOTOXIN | DUKE UNIVERSITY (US) | 1996-09-10 | — | — | US | claimed |
| US-5449688-A | Nitric oxide synthase inhibitor or scavenger | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-09-12 | — | — | US | claimed |
| EP-0603335-A4 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE. | US HEALTH (US) | 1995-07-05 | — | — | EP | claimed |
| EP-0603335-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-06-29 | — | — | EP | claimed |
| US-5225440-A | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-07-06 | — | — | US | claimed |
| WO-1993005775-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-01 | — | — | WO | claimed |
| JP-7316023-A | — | — | None | — | — | JP | disclosed |
| WO-2024130161-A2 | NOVEL CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF | BIONECURE THERAPEUTICS INC (US) | 2024-06-20 | — | — | WO | disclosed |
| US-5225440-A | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-07-06 | — | — | US | disclosed |
| WO-1993005775-A1 | ATTENUATION OF THE OPIOID WITHDRAWAL SYNDROME BY INHIBITORS OF NITRIC OXIDE SYNTHASE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1993-04-01 | — | — | WO | disclosed |